Patel D, John J, Bodepudi R, et al. Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in Treatment of Patients With Polycystic Ovary Syndrome: A Systemic Review of Metabolic and Cardiovascular Outcomes. Journal For International Medical Graduates. 2024;3(1). doi:10.56570/jimgs.v1i1.149